seanc: "Let's see what sort of deal that comes from ROW."
seanc/others: JIMHO: For value optimisation, probably a good idea to "competitively" split-up the ROW into:
a) A deal for EUROPE (with a BIG EUROPEAN Pharma company) and
b) A deal for ASIA-PACIFIC (with a BIG ASIAN Pharma company)
Time will tell. Should be interesting to see things develop throughout 2022...
wasa
-
- There are more pages in this discussion • 1,817 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.48 |
Change
-0.290(1.73%) |
Mkt cap ! $2.076B | |||
| Open | High | Low | Value | Volume |
| $16.58 | $16.74 | $16.40 | $9.107M | 549.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 864 | $16.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.50 | 1668 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |